Unfortunately, while compounds 11–13 were irreversible Akt inhibitors and displayed submicromolar antiproliferative activity against a number of cancer cell lines, none matched the highly active inhibitor of the same class, borussertib (2), with the most active compounds being related to borussertib 2, albeit less potent. Here, AKT1 is linked to cancer.